Epirubicin Hydrochloride (Teva Parenteral Medicines, Inc.)
Welcome to the PulseAid listing for the Epirubicin Hydrochloride drug offered from Teva Parenteral Medicines, Inc.. This Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Teva Parenteral Medicines, Inc. |
| NON-PROPRIETARY NAME: | Epirubicin Hydrochloride |
| SUBSTANCE NAME: | EPIRUBICIN HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Anthracycline Topoisomerase Inhibitor [EPC],Anthracyclines [Chemical/Ingredient],Topoisomerase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2007-08-09 |
| END MARKETING DATE: | 2017-11-30 |
Epirubicin Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Epirubicin Hydrochloride from Teva Parenteral Medicines, Inc. |
| LABELER NAME: | Teva Parenteral Medicines, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/25mL) |
| START MARKETING DATE: | 2007-08-09 |
| END MARKETING DATE: | 2017-11-30 |
| PRODUCT ID: | 0703-3067_ed91c301-8b50-4322-8052-c05d2ad6cc0a |
| PRODUCT NDC: | 0703-3067 |
| APPLICATION NUMBER: | ANDA065331 |
Other EPIRUBICIN HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
